<table><tr><th>From:</th><th>Masha Drokova</th></tr><tr><td>Sent:</td><td>Wednesday, November 1, 2017 4:21 PM</td></tr><tr><td>To:</td><td>jeffrey E.</td></tr></table>

I'm looking to invest at the company doing Al=based glucose monitoring system for people with diabetes. We made tec= evaluation, talked to a few experts and more a question about the market a=d regulations. Likely no, because it's complex area, but still thinki=g of them.

May be someone in your network who knows this area and c=n advise on this kind of tech?

- Visible text: "Center Health" (top-left)
- Large black rectangular area across image (appears to be redacted or obscured content)
- Likely a memo header/banner (context: "Our memo:" provided)

=div class=""" style="font-weight: normal;">Our memo:

## Pros

— Existing glucometers from big companies are very old-f=shioned and outdated, those companies make their revenue from overpriced st=ips — Direct compet=tors, such as iHealth and Dario have negative customer reviews a=d minor — Uses FDA-approved circuits t= get the approval in an automated manner

Cons

=94 Enormous pressure both from the industry players and companies such as A=ple and Google that try to develop non-invasive glucose monitoring that wit= wipe out test strip products — Young t=am =